Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
NETGEAR
NTGR
$647M
| $7.29M | ﹤0.01% |
297,451
+1,379
| +0.5% | +$37.7K |
|
1827
DXP Enterprises
DXPE
$3B
| $7.29M | ﹤0.01% |
183,105
+4,241
| +2% | +$158K |
|
1828
Southside Bancshares
SBSI
$984M
| $7.29M | ﹤0.01% |
196,275
+4,885
| +3% | +$173K |
|
1829
Adtran
ADTN
$658M
| $7.28M | ﹤0.01% |
736,447
+45,670
| +7% | +$435K |
|
1830
Tompkins Financial
TMP
$1.45B
| $7.28M | ﹤0.01% |
79,547
+913
| +1% | +$78.9K |
|
1831
Orthofix Medical
OFIX
$415M
| $7.26M | ﹤0.01% |
157,287
+15,595
| +11% | +$733K |
|
1832
First Bancorp
FBNC
$2.74B
| $7.26M | ﹤0.01% |
181,885
+2,956
| +2% | +$113K |
|
1833
Kadant
KAI
$3.91B
| $7.26M | ﹤0.01% |
68,889
+1,486
| +2% | +$141K |
|
|
TPTX
1834
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $7.24M | ﹤0.01% |
116,265
+44,962
| +63% | +$2.14M |
|
|
DCPH
1835
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.23M | ﹤0.01% |
116,144
+7,530
| +7% | +$358K |
|
|
WLH
1836
DELISTED
WILLIAM LYON HOMES
WLH
| $7.22M | ﹤0.01% |
361,131
+42,806
| +13% | +$875K |
|
|
ECHO
1837
DELISTED
Echo Global Logistics, Inc.
ECHO
| $7.21M | ﹤0.01% |
348,543
+18,767
| +6% | +$392K |
|
1838
Lantheus
LNTH
$6.59B
| $7.21M | ﹤0.01% |
351,552
-23,959
| -6% | -$485K |
|
1839
Stoneridge
SRI
$201M
| $7.2M | ﹤0.01% |
245,601
+23,719
| +11% | +$730K |
|
|
BGG
1840
DELISTED
Briggs & Stratton Corp.
BGG
| $7.12M | ﹤0.01% |
1,068,934
+172,949
| +19% | +$1.06M |
|
|
DRNA
1841
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.11M | ﹤0.01% |
322,895
-25,930
| -7% | -$522K |
|
1842
Seaboard Corp
SEB
$4.08B
| $7.1M | ﹤0.01% |
1,671
+26
| +2% | +$109K |
|
1843
AdvanSix
ASIX
$446M
| $7.1M | ﹤0.01% |
355,495
+12,750
| +4% | +$279K |
|
1844
Garrett Motion
GTX
$5.35B
| $7.09M | ﹤0.01% |
709,360
+101,609
| +17% | +$1.04M |
|
|
CSW
1845
CSW Industrials
CSW
$5.59B
| $7.08M | ﹤0.01% |
91,969
+1,606
| +2% | +$115K |
|
|
GLDD
1846
DELISTED
Great Lakes Dredge & Dock
GLDD
| $7.05M | ﹤0.01% |
622,323
-60,123
| -9% | -$642K |
|
1847
Zoom
ZM
$32.2B
| $7.03M | ﹤0.01% |
103,264
+4,193
| +4% | +$289K |
|
1848
National CineMedia
NCMI
$252M
| $6.98M | ﹤0.01% |
95,716
+3,413
| +4% | +$257K |
|
1849
Vanda Pharmaceuticals
VNDA
$304M
| $6.97M | ﹤0.01% |
424,475
-104,103
| -20% | -$1.57M |
|
1850
Theravance Biopharma
TBPH
$878M
| $6.94M | ﹤0.01% |
268,100
+9,237
| +4% | +$180K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.